Providence Capital Advisors’s CVS Health CVS Stock Holding History

Providence Capital Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-219	Closed	-$12.9K	–	358
2024 Q2	$12.9K	Hold	219	–	–	﹤0.01%	232
2024 Q1	$17.5K	Buy	219 +19	+10%	+$1.45K	﹤0.01%	212
2023 Q4	$15.8K	Hold	200	–	–	﹤0.01%	223
2023 Q3	$14K	Hold	200	–	–	﹤0.01%	220
2023 Q2	$13.8K	Sell	200 -400	-67%	-$28.5K	﹤0.01%	205
2023 Q1	$44.6K	Hold	600	–	–	0.01%	148
2022 Q4	$55.9K	Hold	600	–	–	0.02%	138
2022 Q3	$57K	Hold	600	–	–	0.02%	132
2022 Q2	$56K	Hold	600	–	–	0.02%	136
2022 Q1	$61K	Hold	600	–	–	0.01%	158
2021 Q4	$62K	Hold	600	–	–	0.02%	142
2021 Q3	$51K	Hold	600	–	–	0.02%	151
2021 Q2	$50K	Hold	600	–	–	0.02%	141
2021 Q1	$45K	Hold	600	–	–	0.02%	141
2020 Q4	$41K	Buy	+600	New	+$39K	0.02%	152
2018 Q1	–	Sell	-64	Closed	-$5K	–	254
2017 Q4	$5K	Buy	+64	New	+$4.65K	﹤0.01%	257

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Providence Capital Advisors's CVS Position: Q3 2024 in Review

Providence Capital Advisors sold out of CVS Health (CVS) in Q3 2024, closing a stake of 219 shares — an estimated $12.9K sold.

Providence Capital Advisors first reported a position in CVS in Q4 2017 and held it in 16 quarters. The position peaked at $62K in Q4 2021. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

Providence Capital Advisors reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
Providence Capital Advisors sold 219 CVS Health shares in Q3 2024, an estimated $12.9K.
Providence Capital Advisors first reported a position in CVS Health in Q4 2017 and held it in 16 quarters.
Providence Capital Advisors's CVS Health position peaked at $62K in Q4 2021.
1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Providence Capital Advisors's 13F filing for Q3 2024, filed 13 Nov 2024.